NeuClone Starts Trial For Ustekinumab Biosimilar

NeuLara Rival To Stelara Enters Phase I Clinical Trial

After extensive pre-clinical testing, NeuClone has commenced dosing in a Phase I clinical trial for its Stelara biosimilar candidate, NeuLara.

People_Orange_Icon
NeuClone’s NeuLara enters the clinical development stage • Source: Shutterstock

More from Biosimilars

More from Products